To Determine the Ability of a New Product Formulation to Remineralize an Early Caries Lesion by an In-situ Study
Primary Purpose
Dental Caries
Status
Withdrawn
Phase
Phase 2
Locations
Study Type
Interventional
Intervention
Control toothpaste containing no anti-cavity ingredients
Experimental toothpaste containing fluoride and amino acid (arginine)
Fluoride toothpaste containing fluoride as the anti-cavity ingredient
Sponsored by
About this trial
This is an interventional treatment trial for Dental Caries
Eligibility Criteria
Inclusion Criteria:
- Male and/or female subjects 18 to 50 years inclusive
- Minimum of 20 natural uncrowned teeth (excluding third molars) must be present
- Willing to wear retainer 24 hours per day
- No active, unrestored cavities
- Have normal salivary flow rate (stimulated and unstimulated flow of ≥0.7 ml/min and ≥ 0.2 ml/min respectively) ascertained from a preliminary sialometry
- Available throughout entire study
- Willing to use only assigned products for oral hygiene throughout the duration of the study
- Must give written informed consent
- Must be in good general health
- No known history of allergy to personal care/consumer products or their ingredients, relevant to any ingredient in the test products as determined by the dental/medical professional monitoring the study
Exclusion Criteria:
- Advanced periodontal disease
- Medical condition which requires premedication prior to dental visits/procedures
- Not enough teeth to secure the oral retainer
- Diseases of the soft or hard oral tissues
- Wear an Orthodontic appliances
- Impaired salivary function
- Current use drugs that can affect salivary flow
- Use antibiotics one (1) month prior to or during this study
- Pregnant or breastfeeding
- Participate in another clinical study one (1) week prior to the start of the washout period or during this 9-week study period
- Use tobacco products
- Allergic to common toothpaste ingredients
- Allergic to amino acids
- Immune compromised individuals (HIV, AIDS, immuno-suppressive drug therapy)
Sites / Locations
Arms of the Study
Arm 1
Arm 2
Arm 3
Arm Type
Placebo Comparator
Experimental
Active Comparator
Arm Label
Fluoride free, silica based toothpaste
fluoride + amino acid in a silica toothpaste
1450 ppm fluoride in a silica base toothpaste
Arm Description
Control toothpaste containing no anti-cavity ingredients
Experimental toothpaste containing fluoride and amino acid (arginine)
Fluoride toothpaste containing fluoride as the anti-cavity ingredient
Outcomes
Primary Outcome Measures
Mineral Change (delta Z)
Tooth samples of human enamel are placed in a retainer and worn by each study subject. Enamel block samples will be x-rayed and analyzed for mineral level (volume % of micrometer of lesions , vol% µm) before being placed in the retainer. These baseline values will be compared with the post use delta mineral change (∆ Z).
Mineral Change (delta Z)
Tooth samples of human enamel are placed in a retainer and worn by each study subject. After 2 weeks of wearing the study retainer, samples from the retainer will be x-rayed and analyzed for mineral level (volume % of micrometer of lesions , vol% µm). These post use values will be compared to the Baseline values to give a delta mineral change (∆ Z).
Secondary Outcome Measures
Full Information
1. Study Identification
Unique Protocol Identification Number
NCT02388178
Brief Title
To Determine the Ability of a New Product Formulation to Remineralize an Early Caries Lesion by an In-situ Study
Official Title
Assessment of 1450 Ppm Fluoride/Arginine Toothpaste Using an Intra-oral Remineralization-demineralization Model.
Study Type
Interventional
2. Study Status
Record Verification Date
September 2022
Overall Recruitment Status
Withdrawn
Why Stopped
The study was stopped due to business reasons.
Study Start Date
April 2015 (undefined)
Primary Completion Date
July 2015 (Anticipated)
Study Completion Date
July 2015 (Anticipated)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Colgate Palmolive
4. Oversight
Data Monitoring Committee
No
5. Study Description
Brief Summary
This is a double blind, cross-over, controlled clinical trial utilizing thirty (30) adults to evaluate remineralization of early caries lesions.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Dental Caries
7. Study Design
Primary Purpose
Treatment
Study Phase
Phase 2
Interventional Study Model
Crossover Assignment
Masking
ParticipantInvestigatorOutcomes Assessor
Allocation
Randomized
Enrollment
0 (Actual)
8. Arms, Groups, and Interventions
Arm Title
Fluoride free, silica based toothpaste
Arm Type
Placebo Comparator
Arm Description
Control toothpaste containing no anti-cavity ingredients
Arm Title
fluoride + amino acid in a silica toothpaste
Arm Type
Experimental
Arm Description
Experimental toothpaste containing fluoride and amino acid (arginine)
Arm Title
1450 ppm fluoride in a silica base toothpaste
Arm Type
Active Comparator
Arm Description
Fluoride toothpaste containing fluoride as the anti-cavity ingredient
Intervention Type
Drug
Intervention Name(s)
Control toothpaste containing no anti-cavity ingredients
Other Intervention Name(s)
Fluoride free toothpaste control
Intervention Description
Brush whole mouth with study toothpaste 2x/day for the 2 week test period. Each brushing routine is 1 minute whole mouth brushing with oral retainer in mouth, spit out toothpaste residue and wait for 1 minute before rinsing with water.
Intervention Type
Drug
Intervention Name(s)
Experimental toothpaste containing fluoride and amino acid (arginine)
Other Intervention Name(s)
Experimental toothpaste
Intervention Description
Brush whole mouth with study toothpaste 2x/day for the 2 week test period. Each brushing routine is 1 minute whole mouth brushing with oral retainer in mouth, spit out toothpaste residue and wait for 1 minute before rinsing with water.
Intervention Type
Drug
Intervention Name(s)
Fluoride toothpaste containing fluoride as the anti-cavity ingredient
Other Intervention Name(s)
Fluoride only toothpaste control
Intervention Description
Brush whole mouth with study toothpaste 2x/day for the 2 week test period. Each brushing routine is 1 minute whole mouth brushing with oral retainer in mouth, spit out toothpaste residue and wait for 1 minute before rinsing with water.
Primary Outcome Measure Information:
Title
Mineral Change (delta Z)
Description
Tooth samples of human enamel are placed in a retainer and worn by each study subject. Enamel block samples will be x-rayed and analyzed for mineral level (volume % of micrometer of lesions , vol% µm) before being placed in the retainer. These baseline values will be compared with the post use delta mineral change (∆ Z).
Time Frame
Baseline
Title
Mineral Change (delta Z)
Description
Tooth samples of human enamel are placed in a retainer and worn by each study subject. After 2 weeks of wearing the study retainer, samples from the retainer will be x-rayed and analyzed for mineral level (volume % of micrometer of lesions , vol% µm). These post use values will be compared to the Baseline values to give a delta mineral change (∆ Z).
Time Frame
2 weeks (from Baseline)
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
50 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria:
Male and/or female subjects 18 to 50 years inclusive
Minimum of 20 natural uncrowned teeth (excluding third molars) must be present
Willing to wear retainer 24 hours per day
No active, unrestored cavities
Have normal salivary flow rate (stimulated and unstimulated flow of ≥0.7 ml/min and ≥ 0.2 ml/min respectively) ascertained from a preliminary sialometry
Available throughout entire study
Willing to use only assigned products for oral hygiene throughout the duration of the study
Must give written informed consent
Must be in good general health
No known history of allergy to personal care/consumer products or their ingredients, relevant to any ingredient in the test products as determined by the dental/medical professional monitoring the study
Exclusion Criteria:
Advanced periodontal disease
Medical condition which requires premedication prior to dental visits/procedures
Not enough teeth to secure the oral retainer
Diseases of the soft or hard oral tissues
Wear an Orthodontic appliances
Impaired salivary function
Current use drugs that can affect salivary flow
Use antibiotics one (1) month prior to or during this study
Pregnant or breastfeeding
Participate in another clinical study one (1) week prior to the start of the washout period or during this 9-week study period
Use tobacco products
Allergic to common toothpaste ingredients
Allergic to amino acids
Immune compromised individuals (HIV, AIDS, immuno-suppressive drug therapy)
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Bennet Amaechi, PhD, DDS
Organizational Affiliation
University of Texas
Official's Role
Principal Investigator
12. IPD Sharing Statement
Learn more about this trial
To Determine the Ability of a New Product Formulation to Remineralize an Early Caries Lesion by an In-situ Study
We'll reach out to this number within 24 hrs